Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies (Q37045695)

17 August 2017

0 references

1 reference

title

Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studies (English)

1 reference

17 August 2017

0 references

1 reference

Jean Y Chuo

1

1 reference

17 August 2017

Matthew Wiens

series ordinal

2

1 reference

17 August 2017

Mahyar Etminan

series ordinal

3

1 reference

17 August 2017

David A L Maberley

series ordinal

4

1 reference

17 August 2017

publication date

1 November 2007

1 reference

17 August 2017

published in

Ophthalmic Epidemiology

1 reference

17 August 2017

volume

14

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

367-374

1 reference

HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Risk factors for age-related macular degeneration: Pooled findings from three continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Causes and prevalence of visual impairment among adults in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Prevalence of age-related macular degeneration in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Risk factors for age-related maculopathy: the Visual Impairment Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

The prevalence of age-related maculopathy: the visual impairment project

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of 1000 aged individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

A role for local inflammation in the formation of drusen in the aging eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Immunohistochemical localization of C5b-9, S-protein, C3d and apolipoprotein B in human arterial tissues with atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Vascular endothelial growth factor expression in choroidal neovascularization in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

HEpiMA: software for the identification of heterogeneity in meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

The association between statin use and age related maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

A case control study of age related macular degeneration and use of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Risk of macular degeneration in users of statins: cross sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

Relation of Statin Use to the 5-Year Incidence and Progression of Age-Related Maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286580701421684

10.1080/09286580701421684

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference